Moreover, induced phase II enzymes, such as HO-1, have the potential to improve cellular antioxidant capacity and protect against oxidative injury; thus, the induction of HO-1 is a common feature in several neurodegenerative diseases, such as AD and PD [27,28,29]. This evidence concerns the gene HMOX1 and Alzheimer disease.